1. "Elsevier Inc."
Formats
  1. Journal Article (7386)
  2. Meeting Abstract (4694)
  3. Review (617)
  4. Book Section (538)
  5. Editorial (250)
  6. Conference Paper (138)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4610)
  2. Surgery (3546)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2651)
  5. Radiation Oncology, Department of (2158)
  6. GSK Faculty (1937)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (240)
  2. 2024 (784)
  3. 2023 (762)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2610)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (967)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (524)
  6. Journal of Sexual Medicine (435)

More Publications

Publishers
  1. Elsevier Inc. (13855)

Results (13855)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensity-modulated versus 3D conformal radiation therapy for limited-stage small cell lung cancer
    Meeting Abstract

    Perez, C. A.; Rimner, A.; McLane, A.; Gelblum, D. Y.; Gewanter, R. M.; Krug, L. M.; Pietanza, M. C.; Rosenzweig, K. E.; Wu, A. J.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Visceral pleural Invasion does not impact on recurrence-free or overall survival in lung adenocarcinoma <= 2cm
    Meeting Abstract

    Nitadori, J.; Colovos, C.; Kadota, K.; Sima, C. S.; Rusch, V. W.; Travis, W. D.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • The select study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Neal, J. W.; Pennell, N. A.; Govindan, R.; Heist, R. S.; Shaw, A. T.; Muzikansky, A.; Jänne, P. A.; Lynch, T. J.; Azzoli, C. G.; Sequist, L. V.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for primary lung cancers > 3cm
    Meeting Abstract

    Cuaron, J. J.; Yorke, E.; McLane, A.; Liu, F.; Jackson, A.; Mychalczak, B.; Wu, A.; Rosenzweig, K.; Rimner, A.
    Journal of Thoracic Oncology (2012)

    Fulltext@MSK | Save
  • Parathyroid carcinoma: Challenges in diagnosis and treatment
    Journal Article

    Mohebati, A.; Shaha, A.; Shah, J.
    Hematology/Oncology Clinics of North America (2012)

    Fulltext@MSK | Save
  • CTLA-4 blockade for melanoma: Past, present and future
    Meeting Abstract

    Wolchok, J.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • BAY80-6946 is a potent and selective PI3K inhibitor that induces apoptosis in breast cancers by blocking AKT and non-AKT PI3K effector pathways
    Meeting Abstract

    Will, M.; Toy, W.; Patel, P.; Rodrik-Outmezguine, V.; Schneider, C.; Paul, J.; Liu, N.; Rosen, N.; Chandarlapaty, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Patterns of tumor evolution in high-grade ovarian adenocarcinoma
    Meeting Abstract

    Verhaak, R. G. W.; Qiao, Y.; Kim, H.; Chang, K.; Munzy, D.; Gibbs, R. A.; Marth, G.; Levine, D. A.; Wheeler, D. A.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Proffered paper: Next generation RNAi mouse models for drug discovery and toxicology assessment
    Meeting Abstract

    Premsrirut, P.; Fellmann, C.; Hannon, G. J.; Lowe, S. W.; Zuber, J.; Elledge, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Next generation RNAi mouse models for drug discovery and toxicology assessment
    Meeting Abstract

    Premsrirut, P.; Fellmann, C.; Dow, L.; Lowe, S.; Zuber, J.; Hannon, G.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save